In summary, our data affirm that SNHG4 mitigates pulmonary inflammation, apoptosis, and oxidative damage mediated by COPD through the regulation of the miR-409-3p/FHL1 axis. This evidence concerns the gene FHL1 and chronic obstructive pulmonary disease.